Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Alfredo Smiriglia(University of Florence), Andrea Morandi(University of Florence)
Cited by 20
Related Papers
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts
|Oncotarget|2016|33
FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1